Goldman Sachs Europe CORE Equity Portfolio Other Currency Acc USD HedgedRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -4.8 | 26.5 | 3.4 | 10.3 | 12.2 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 21/11/2024 | USD 16.12 | |
Day Change | 0.52% | |
Morningstar Category™ | Other Equity | |
ISIN | LU1829250122 | |
Fund Size (Mil) 21/11/2024 | EUR 2013.71 | |
Share Class Size (Mil) 21/11/2024 | USD 3.52 | |
Max Initial Charge | 5.50% | |
Ongoing Charge 16/02/2024 | 1.42% |
Investment Objective: Goldman Sachs Europe CORE Equity Portfolio Other Currency Acc USD Hedged |
The Portfolio seeks long-term capital appreciation by investing primarily in equity securities of European companies. Utilising the CORE® strategy, as detailed at the start of Section C, the Portfolio will, under normal circumstances, invest at least two thirds of its net assets in equity and/or equity related Transferable Securities and Permitted Funds which provide exposure to companies that are domiciled in, or which derive the predominant proportion of their revenues or profits from Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Len Ioffe 01/01/2007 | ||
Takashi Suwabe 01/01/2013 | ||
Click here to see others | ||
Inception Date 08/06/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Goldman Sachs Europe CORE Equity Portfolio Other Currency Acc USD Hedged | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 4.44 |
Nestle SA | Consumer Defensive | 3.64 |
SAP SE | Technology | 3.37 |
Roche Holding AG | Healthcare | 3.34 |
Novartis AG Registered Shares | Healthcare | 3.25 |
Increase Decrease New since last portfolio | ||
Goldman Sachs Europe CORE Equity Portfolio Other Currency Acc USD Hedged |